Radiotherapy & Oncology
Volume 87, Issue 1 , Pages 29-34 , April 2008

Involved-field radiotherapy is effective for patients 70 years old or more with early stage non-small cell lung cancer

  • Hui Ming Yu

      Affiliations

    • Department of Oncology, Shandong University Medical School, Qilu Hospital, Jinan, PR China
    • These authors contributed equally to this work.
    • ,
  • Yun Fang Liu

      Affiliations

    • Department of Medical Diagnosis, Shandong University, Jinan, PR China
    • Corresponding Author InformationCorresponding authors. Ming Hou and Yun Fang Liu, Department of Oncology, Shandong University Medical School, Qilu Hospital, No. 107, Wen Hua Xi Road, Shandong 250012, Jinan, PR China.
    • These authors contributed equally to this work.
    • ,
  • Jin Ming Yu

      Affiliations

    • Department of Radiation Oncology, Shandong Tumor Hospital, Jinan, PR China
    • ,
  • Jie Liu

      Affiliations

    • Department of Radiation Oncology, Shandong Province Hospital, Jinan, PR China
    • ,
  • Yuxia Zhao

      Affiliations

    • Department of Oncology, Shandong University Medical School, Qilu Hospital, Jinan, PR China
    • ,
  • Ming Hou

      Affiliations

    • Department of Oncology, Shandong University Medical School, Qilu Hospital, Jinan, PR China
    • Corresponding Author InformationCorresponding authors. Ming Hou and Yun Fang Liu, Department of Oncology, Shandong University Medical School, Qilu Hospital, No. 107, Wen Hua Xi Road, Shandong 250012, Jinan, PR China.

Received 27 May 2007 ,Revised 26 December 2007 ,Accepted 3 January 2008.

References 

  1. Jeremic B, Classen J, Bamberg M. Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002;54:119–130
  2. Cheung PC, Mackillop WJ, Dixon P, et al. Involved-field radiotherapy alone for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2000;48:703–710
  3. Hayakawa K, Mitsuhashi N, Saito Y, et al. Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer. 1999;26:137–142
  4. Zhao LJ, West BT, Hayman JA, et al. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;68:103–110
  5. Bral S, Parijs HV, Soete G, et al. A feasibility study of image-guided hypofractionated conformal arc therapy for inoperable patients with localized non-small cell lung cancer. Radiat Oncol. 2007;84:252–256
  6. Morita k, Fuwa N, Suzuki YS, et al. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients. Radiat Oncol. 1997;42:31–36
  7. Koto M, Takai Y, Ogawa Y, et al. A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. Radiat Oncol. 2007;85:429–434
  8. Krol AD, Aussems P, Noordijik EM, et al. Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation?. Int J Radiat Oncol Biol Phys. 1996;34:297–302
  9. Noordijk EM, vd Poest Clement E, Hermans J, et al. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother Oncol. 1988;13:83–89
  10. Kupelian PA, Komaki R, Allen P. Prognostic factors in the treatment of node-negative non-small cell lung carcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys. 1996;36:607–613
  11. Grills IS, Yan D, Martinez AA, et al. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys. 2003;57:875–890
  12. Murshed H, Liu HH, Liao Z, et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;58:1258–1267
  13. Fang LC, Komaki R, Allen P, et al. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:108–116
  14. Langer CJ. Elderly patients with lung cancer: biases and evidence. Curr Treat Options Oncol. 2002;3:85–102
  15. Nugent WC, Edney MT, Hammerness PG, et al. Non-small cell lung cancer at the extremes of age: impact on diagnosis and treatment. Ann Thorac Surg. 1997;63:193–197
  16. Faria SL, Souhami L, Portelance L, Duclos M, Vuong T, Small D. Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer. Radiat Oncol. 2006;1:42–48
  17. McGarry RC, Papiez L, Williams M, et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys. 2005;15,63:1010–1015
  18. Hayakawa K, Mitsuhashi N, Katano S, et al. High-dose radiation therapy for elderly patients with inoperable or unresectable non-small cell lung cancer. Lung Cancer. 2001;32:81–88
  19. Gauden SJ, Tripcony L. The curative treatment by radiation therapy alone of stage I non-small cell lung cancer in a geriatric population. Lung Cancer. 2001;32:71–79
  20. Rosenzweig KE, Sura S, Jackson A, et al. Involved-field radiation therapy for inoperable non small-cell lung cancer. J Clin Oncol. 2007;25:5557–5561
  21. De Ruysscher D, Wanders R, van Haren E, et al. HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007 Nov 23.
  22. Hoyer M, Roed H, Hansen AT, et al. prospective study on stereotactic radiotherapy of limited-stage non-small –cell lung cancer. Int J Radiat Oncol Biol Phys. 2006;64:s128–s135
  23. Wulf J, Haedinger U, Oppitz U, et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys. 2004;60:186–196
  24. Hiraoka M, M atsuo Y, Nagata Y. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer. Cancer Radiother. 2007;11:32–35
  25. Chapet O, Khodri M, Jalade P, et al. Potential benefits of using non coplanar field and intensity modulated radiation therapy to preserve the heart in irradiation of lung tumors in the middle and lower lobes. Radiother Oncol. 2006;80:333–340
  26. Sibley GS, Jamieson TA, Marks LB, et al. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the duke experience. Int J Radiat Oncol Biol Phys. 1998;40:149–154
  27. Tingyi X, Hongqi L, Qingxuan S, et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006;66:117–125
  28. Rosenzweig KE, Sim SE, Mychalczak B, Braban LE, Schindelheim R, Leibel SA. Elective nodal irradiation in the treatment of non small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys. 2001;50:681–685
  29. Sibley GS. Radiation therapy for patients with medically inoperable stage I non small cell lung carcinoma: smaller volumes and higher doses – a review. Cancer. 1998;82:433–438
  30. Perez CA, Pajak TF, Rubin P. Long-term observations of the patterns of failure with unresectable non-small cell carcinoma of the lung treated with definitive radiotherapy. Cancer. 1987;59:1874–1881
  31. Kong FM, Ten Haken RK, Schipper MJ, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys. 2005;63:324–333
  32. Jeremic B. Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in non-small cell lung cancer (NSCLC): enough to convert no-elective into elective nodal irradiation (ENI)?. Radiother Oncol. 2004;71:123–125
  33. Belderbos JS, Heemsbergen WD, De Jaeger K, Baas P, Lebesque JV. Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:126–134
  34. Slotman BJ, Njo KH, Karim AB. Curative radiotherapy for technically operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1994;29:33–37

PII: S0167-8140(08)00033-9

doi: 10.1016/j.radonc.2008.01.008

Radiotherapy & Oncology
Volume 87, Issue 1 , Pages 29-34 , April 2008

Article Tools

* Image Usage & Resolution